4. 85 3. 224 A 8, 1989 Man O for an extended period of time. The prostamide component 4s
63.457 A 9, 1989 g may be associated with a biodegradable polymer matrix. Such 4s65s46 …

60 Provisional a lication No. 60/288,373,? led on Ma.......() 3, 2001, provigional application
No. 60/291,340,? led The? mvempn provldes a mlmamilzeq'Implantable dmg on May 16 …

BACKGROUND 0001. This invention relates to methods for extended treatment of an ocular
condition. In particular, the present invention releases to methods for extended treatment of …

A coating composition for use in coating implantable medical devices to improve their ability
to release bioactive agents in vivo. The coating composition is particularly adapted for use …

US PATENT DOCUMENTS 6, 007833. A 12/1999 Chudzik 6,013,099 A 1/2000 Dinh
4,826,759 A 5/1989 Guire 6,077,698. A 6/2000 Swan 4,916,193 A 4/1990 Tang et al …

Compositions, and methods of using such compositions, useful for injection into the
posterior segments of human or animal eyes are provided. Such compositions include …

The invention provides retrievable devices for sustained delivery of bioactive agent to a site
within a patient, the devices including a body member having a direction of exten Sion, a …

Methods and systems are disclosed for creating an aqueous flow pathway in the trabecular
meshwork, juxtacanalicular trabecular meshwork and Schlemm's canal of an eye for …

Featured is a method for instilling one or more bioactive agents into ocular tissue within an
eye of a patient for the treatment of an ocular condition, the method comprising concurrently …

Featured is a methodology for administering a therapeutic medium to the posterior Segment
of an eye including instill ing or disposing the therapeutic medium Sub-retinally. In particular …